305 related articles for article (PubMed ID: 36195615)
1. Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer.
Tian Y; Li Q; Yang Z; Zhang S; Xu J; Wang Z; Bai H; Duan J; Zheng B; Li W; Cui Y; Wang X; Wan R; Fei K; Zhong J; Gao S; He J; Gay CM; Zhang J; Wang J; Tang F
Signal Transduct Target Ther; 2022 Oct; 7(1):346. PubMed ID: 36195615
[TBL] [Abstract][Full Text] [Related]
2. Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities.
Desai P; Takahashi N; Kumar R; Nichols S; Malin J; Hunt A; Schultz C; Cao Y; Tillo D; Nousome D; Chauhan L; Sciuto L; Jordan K; Rajapakse V; Tandon M; Lissa D; Zhang Y; Kumar S; Pongor L; Singh A; Schroder B; Sharma AK; Chang T; Vilimas R; Pinkiert D; Graham C; Butcher D; Warner A; Sebastian R; Mahon M; Baker K; Cheng J; Berger A; Lake R; Abel M; Krishnamurthy M; Chrisafis G; Fitzgerald P; Nirula M; Goyal S; Atkinson D; Bateman NW; Abulez T; Nair G; Apolo A; Guha U; Karim B; El Meskini R; Ohler ZW; Jolly MK; Schaffer A; Ruppin E; Kleiner D; Miettinen M; Brown GT; Hewitt S; Conrads T; Thomas A
Cell Rep Med; 2024 Jun; 5(6):101610. PubMed ID: 38897168
[TBL] [Abstract][Full Text] [Related]
3. Cell-autonomous immune gene expression is repressed in pulmonary neuroendocrine cells and small cell lung cancer.
Cai L; Liu H; Huang F; Fujimoto J; Girard L; Chen J; Li Y; Zhang YA; Deb D; Stastny V; Pozo K; Kuo CS; Jia G; Yang C; Zou W; Alomar A; Huffman K; Papari-Zareei M; Yang L; Drapkin B; Akbay EA; Shames DS; Wistuba II; Wang T; Johnson JE; Xiao G; DeBerardinis RJ; Minna JD; Xie Y; Gazdar AF
Commun Biol; 2021 Mar; 4(1):314. PubMed ID: 33750914
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Bioinformatics Analysis Identifies Tumor Microenvironment and Immune-related Genes in Small Cell Lung Cancer.
Song Y; Sun Y; Sun T; Tang R
Comb Chem High Throughput Screen; 2020; 23(5):381-391. PubMed ID: 32264809
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution.
Dora D; Rivard C; Yu H; Bunn P; Suda K; Ren S; Lueke Pickard S; Laszlo V; Harko T; Megyesfalvi Z; Moldvay J; Hirsch FR; Dome B; Lohinai Z
Mol Oncol; 2020 Sep; 14(9):1947-1965. PubMed ID: 32506804
[TBL] [Abstract][Full Text] [Related]
6. Novel Hybrid Phenotype Revealed in Small Cell Lung Cancer by a Transcription Factor Network Model That Can Explain Tumor Heterogeneity.
Udyavar AR; Wooten DJ; Hoeksema M; Bansal M; Califano A; Estrada L; Schnell S; Irish JM; Massion PP; Quaranta V
Cancer Res; 2017 Mar; 77(5):1063-1074. PubMed ID: 27932399
[TBL] [Abstract][Full Text] [Related]
7. Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review.
Xiong J; Barayan R; Louie AV; Lok BH
Semin Cancer Biol; 2022 Nov; 86(Pt 2):521-542. PubMed ID: 35917883
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of chemokines in small cell lung cancer: Road signs for metastasis, heterogeneity, and immune response.
Khan P; Fatima M; Khan MA; Batra SK; Nasser MW
Semin Cancer Biol; 2022 Dec; 87():117-126. PubMed ID: 36371025
[TBL] [Abstract][Full Text] [Related]
9. YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer.
Horie M; Saito A; Ohshima M; Suzuki HI; Nagase T
Cancer Sci; 2016 Dec; 107(12):1755-1766. PubMed ID: 27627196
[TBL] [Abstract][Full Text] [Related]
10. Single-cell transcriptome analysis reveals cellular and molecular alterations in small cell lung cancer tumors following chemotherapy.
Cheng C; Zhu G; Li Y; Wang H; Wang S; Li C; Feng J; Wang Z; Li W
Int J Cancer; 2023 Sep; 153(6):1273-1286. PubMed ID: 37334524
[TBL] [Abstract][Full Text] [Related]
11. Dynamic phenotypic reprogramming and chemoresistance induced by lung fibroblasts in small cell lung cancer.
Lu Y; Li H; Zhao P; Tian L; Liu Y; Sun X; Cheng Y
Sci Rep; 2024 Feb; 14(1):2884. PubMed ID: 38311608
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer.
Li F; Yang Y; Xu Y; Li K; Song L; Xue Y; Dong D
Medicine (Baltimore); 2023 Jan; 102(4):e32781. PubMed ID: 36705391
[TBL] [Abstract][Full Text] [Related]
13. The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cells.
Kalari S; Jung M; Kernstine KH; Takahashi T; Pfeifer GP
Oncogene; 2013 Jul; 32(30):3559-68. PubMed ID: 22907430
[TBL] [Abstract][Full Text] [Related]
14. Immune Cell Infiltration May Be a Key Determinant of Long-Term Survival in Small Cell Lung Cancer.
Muppa P; Parrilha Terra SBS; Sharma A; Mansfield AS; Aubry MC; Bhinge K; Asiedu MK; de Andrade M; Janaki N; Murphy SJ; Nasir A; Van Keulen V; Vasmatzis G; Wigle DA; Yang P; Yi ES; Peikert T; Kosari F
J Thorac Oncol; 2019 Jul; 14(7):1286-1295. PubMed ID: 31078775
[TBL] [Abstract][Full Text] [Related]
15. Intratumor heterogeneity is associated with less CD8
Zhang C; Li Z; Shang X; Zhao C; Wang H
Clin Transl Oncol; 2023 Apr; 25(4):1043-1052. PubMed ID: 36422799
[TBL] [Abstract][Full Text] [Related]
16. Genomic and transcriptomic profiling of combined small-cell lung cancer through microdissection: unveiling the transformational pathway of mixed subtype.
Ma W; Zhou T; Song M; Liu J; Chen G; Zhan J; Ji L; Luo F; Gao X; Li P; Xia X; Huang Y; Zhang L
J Transl Med; 2024 Feb; 22(1):189. PubMed ID: 38383412
[TBL] [Abstract][Full Text] [Related]
17. Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study.
Thomas A; Vilimas R; Trindade C; Erwin-Cohen R; Roper N; Xi L; Krishnasamy V; Levy E; Mammen A; Nichols S; Chen Y; Velcheti V; Yin F; Szabo E; Pommier Y; Steinberg SM; Trepel JB; Raffeld M; Young HA; Khan J; Hewitt S; Lee JM
J Thorac Oncol; 2019 Aug; 14(8):1447-1457. PubMed ID: 31063862
[TBL] [Abstract][Full Text] [Related]
18. Ascl1-induced Wnt11 regulates neuroendocrine differentiation, cell proliferation, and E-cadherin expression in small-cell lung cancer and Wnt11 regulates small-cell lung cancer biology.
Tenjin Y; Kudoh S; Kubota S; Yamada T; Matsuo A; Sato Y; Ichimura T; Kohrogi H; Sashida G; Sakagami T; Ito T
Lab Invest; 2019 Nov; 99(11):1622-1635. PubMed ID: 31231131
[TBL] [Abstract][Full Text] [Related]
19. Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer.
Roper N; Velez MJ; Chiappori A; Kim YS; Wei JS; Sindiri S; Takahashi N; Mulford D; Kumar S; Ylaya K; Trindade C; Manukyan I; Brown AL; Trepel JB; Lee JM; Hewitt S; Khan J; Thomas A
Nat Commun; 2021 Jun; 12(1):3880. PubMed ID: 34162872
[TBL] [Abstract][Full Text] [Related]
20. The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer.
Horn L; Reck M; Spigel DR
Oncologist; 2016 Aug; 21(8):910-21. PubMed ID: 27354668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]